Drug intelligence / Profile preview

isthmin-1

Development stage
Preclinical
Lead developer
Chinese academic laboratories
Modality
Recombinant Proteins and Enzymes
Administration
Intraperitoneal (preclinical/animal), Intratracheal (animal/preclinical), Not Established For Human Therapy
01

Overview

Isthmin-1 is a secreted protein and adipokine, recently identified as a bioactive polypeptide hormone involved in multiple physiological and pathological processes, including metabolism, angiogenesis, and inflammation. Mechanistically, isthmin-1 activates the PI3K–AKT signaling pathway—independently of the insulin and insulin-like growth factor (IGF) receptors—to promote glucose uptake in adipocytes, suppress hepatic lipid synthesis, improve glucose tolerance, and ameliorate hepatic steatosis in preclinical models. Isthmin-1 also plays roles in vascular permeability, apoptosis, inhibition of endothelial cell proliferation (via αvβ5 integrin), and modulates airway inflammation through stimulation of adiponectin via the GRP78 receptor. Recombinant isthmin-1 (rISM1) has demonstrated promise as a potential therapeutic agent for type 2 diabetes, fatty liver disease, and allergic airway inflammation in animal models[1][3][5][6][2][7][9].

Other names
IsthminISM1 polypeptideISM-1 polypeptideISM 1 polypeptiderecombinant Ism1rISM1rISM-1rISM 1
02

Targets

HSPA5 (Heat shock protein family A member 5)αVβ5 (Integrin αVβ5)

Beyond the preview

Go deeper on isthmin-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isthmin-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call